Rubric Capital Management and Velan Capital reached an agreement with Heron Therapeutics (HRTX)
Want to read more?
Subscribe to snowballresearch.com to keep reading this exclusive post.
Recent Posts
See AllKey Summary: On December 31, 2024, BML Investment Partners (9.9%) opposes the proposed PIPE transaction Market Cap: $77 million | ...
Key Summary: On December 31, 2024, Baron Capital Group (18%) opposes the proposed "going private" transaction of the company. Market...
INDEX Sherborne Investors Amends Agreement with Navient Corp (NAVI) Wynnefield Group's Director Nominees were elected to the Board of...